Artepillin

Artepillin

SCHEMBL2138507

CC(C)=CCc1cc(C=CC(=O)O)cc(CC=C(C)C)c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 14/20 1.00
AKR1B10 O60218 2/20 1.00
AKR1B1 P15121 2/20 1.00
MMP2 P08253 1/20 1.00
PAK1 Q13153 1/20 1.00
ALOX5 P09917 2/20 0.62
PTGES O14684 1/20 0.62
NFKB1 P19838 1/20 0.62
STAT3 P40763 1/20 0.62
NFKB2 Q00653 1/20 0.62
RELA Q04206 1/20 0.62
PTPN1 P18031 2/20 0.61
AKR1C2 P52895 12/20 0.60
AKR1C4 P17516 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
PKM P14618 1/20 0.49
PTGS1 P23219 1/20 0.49
PTGS2 P35354 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Artepillin SCHEMBL1229229 1.00 AKR1C3 (1.00) AKR1C3AKR1B10AKR1B1MMP2PAK1
Artepillin SCHEMBL7128580 1.00 AKR1C3 (1.00) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL25890163 0.95 AKR1C3 (0.91) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL26422962 0.95 AKR1C3 (0.91) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL8467360 0.92 AKR1C3 (0.86) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL8467358 0.92 AKR1C3 (0.86) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL23742688 0.92 AKR1C3 (0.84) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL11036838 0.92 AKR1C3 (0.84) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL29574915 0.92 AKR1C3 (0.84) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL30378377 0.92 AKR1C3 (0.84) AKR1C3AKR1B10AKR1B1MMP2PAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10314918-B2 Jasmonate derivatives and compositions thereof NANOCARE TECHNOLOGIES, INC. (US) 2019-06-11 US claimed
US-20060110520-A1 Active oxygen eliminator derived from natural substance and use thereof MIDORIKAWA KIYOSHI 2006-05-25 US claimed
EP-1621194-A1 ACTIVE OXYGEN ELIMINATOR ORIGINATING IN NATURAL MATERIAL AND USE OF THE SAME Nihon Propolis Co., Ltd. (JP) 2006-02-01 EP claimed
EP-1575689-A2 TYPING NATURAL PRODUCTS Marcucci Ribeiro, Maria Cristina (BR) 2005-09-21 EP claimed
US-20040126437-A1 Typing natural products RIBEIRO MARIA CRISTINA MARCUCC (BR) 2004-07-01 US claimed
US-20030065229-A1 Phenol derivatives, process for preparation of the same and use thereof KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2003-04-03 US claimed
WO-2002051516-A2 TYPING NATURAL PRODUCTS MARCUCCI RIBEIRO MARIA CRISTIN (BR) 2002-07-04 WO claimed
EP-1184362-A1 PHENOL DERIVATIVES, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) 2002-03-06 EP claimed
US-5830914-A 3-(4-HYDROXY-3,5-BIS(3-METHYL-2-BUTENYL)PHENYL)ACRYLIC ACID AND SALTS KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1998-11-03 US claimed
EP-0867187-A1 Propolis extract with improved water-solubility KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1998-09-30 EP claimed
EP-0622068-B1 Hair restorer HAYASHIBARA BIOCHEM LAB (JP) 1998-07-29 EP claimed
US-5710179-A METAL 3-(4-HYDROXY-3,5-BIS(3-METHYL-2-BUTENYL)PHENYL)-2-PROPIONATE KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1998-01-20 US claimed
EP-0800826-A2 Apoptosis-controlling agent KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1997-10-15 EP claimed
US-5556866-A TREATMENT AND PREVENTION OF ALOPECIA KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1996-09-17 US claimed
EP-0622068-A2 Hair restorer KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1994-11-02 EP claimed
JP-7330596-A None JP disclosed
JP-9328425-A None JP disclosed
EP-0622068-A2 Hair restorer KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1994-11-02 EP disclosed
EP-0622068-A2 Hair restorer KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1994-11-02 EP disclosed
JP-H06256177-A ANTIMICROBIAL COMPOSITION AND METHOD FOR PROVIDING ANTIMICROBIAL PROPERTY HAYASHIBARA BIOCHEM LAB INC 1994-09-13 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065229-A1 Phenol derivatives, process for preparation of the same and use thereof ACR, SHARPIN, AGPS AKR1C3 192/4885AKR1B10 851/4885AKR1B1 1008/4885
US-10314918-B2 Jasmonate derivatives and compositions thereof TRAF6, RELA, NFKBIA AKR1C3 3082/4885AKR1B10 2758/4885AKR1B1 1954/4885
US-20040126437-A1 Typing natural products ACHE, BCHE, HLA-C AKR1C3 429/4885AKR1B10 807/4885AKR1B1 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.